New and existing patients will automatically receive the $449 offer on their first purchase of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses
The frequency of review varies depending on the medication, dose, and individual clinical picture, and will be outlined by your prescribing clinician at the outset of treatment
The following frequently asked questions address common concerns and provide clear guidance on ways to manage out-of-pocket expenses
The combination group included those who added a newer generation GLP-1RA (i.e., exenatide once weekly [OW], dulaglutide, semaglutide OW T2D, or oral semaglutide) or dual GLP-1/GIP agonist (tirzepatide T2D) to their SGLT2i (i.e., canagliflozin, dapagliflozin, empagliflozin, ertugliflozin, or bexagliflozin) treatment, with persistent use of a GLP-1RA and SGLT2i for 180 days each and an overlap 120 days, where the gap after exhaustion of days supply was required to be 30 days
The clinical implications of PH in this context are substantial, yet the literature on this topic remains fragmented and inconsistent, hindering the development of standardized diagnostic and therapeutic approaches